Randomized pilot trial of high-dose βINF-1a in patients with inclusion body myositis
Abstract
Get full access to this article
View all available purchase options and get full access to this article.
Supplementary Material
- Download
- 35.00 KB
References
Information & Authors
Information
Published In
Copyright
Publication History
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Sporadic Inclusion Body Myositis at the Crossroads between Muscle Degeneration, Inflammation, and Aging, International Journal of Molecular Sciences, 25, 5, (2742), (2024).https://doi.org/10.3390/ijms25052742
- 272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16–18 June 2023, Hoofddorp, The Netherlands, Neuromuscular Disorders, 37, (36-51), (2024).https://doi.org/10.1016/j.nmd.2024.03.001
- Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis, Neurology, 100, 13, (e1406-e1417), (2023)./doi/10.1212/WNL.0000000000206777
- Exploring challenges in the management and treatment of inclusion body myositis, Current Opinion in Rheumatology, 35, 6, (404-413), (2023).https://doi.org/10.1097/BOR.0000000000000958
- Autoimmune inflammatory myopathies, Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders, (425-460), (2023).https://doi.org/10.1016/B978-0-323-98818-6.00023-6
- Possible future avenues for myositis therapeutics: DM, IMNM and IBM, Best Practice & Research Clinical Rheumatology, 36, 2, (101762), (2022).https://doi.org/10.1016/j.berh.2022.101762
- Revisiting the Role of GSK3, A Modulator of Innate Immunity, in Idiopathic Inclusion Body Myositis, Cells, 10, 11, (3255), (2021).https://doi.org/10.3390/cells10113255
- In Pursuit of an Effective Treatment: the Past, Present and Future of Clinical Trials in Inclusion Body Myositis, Current Treatment Options in Rheumatology, 7, 1, (63-81), (2021).https://doi.org/10.1007/s40674-020-00169-4
- Differential and quantitative neuroimaging characteristics of inclusion body myositis, Journal of Clinical Neuroscience, 72, (244-251), (2020).https://doi.org/10.1016/j.jocn.2019.11.029
- Inclusion body myositis: clinical features and pathogenesis, Nature Reviews Rheumatology, 15, 5, (257-272), (2019).https://doi.org/10.1038/s41584-019-0186-x
- See more
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.